We are live on
!
Find out more
ACM
AlphaCrest Capital Management Portfolio holdings
AUM
$1.64B
1-Year Est. Return
23.4%
This Fund
S&P 500
This Quarter
Est. Return
-16.78%
1 Year Est. Return
-23.4%
3 Year Est. Return
-8.44%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.07B
AUM Growth
+$283M
(+16%)
Cap. Flow
+$660M
Cap. Flow
% of AUM
31.84%
Top 10 Holdings %
Top 10 Hldgs %
6.27%
Holding
1,421
New
201
Increased
658
Reduced
377
Closed
185
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$18.6M |
| 2 |
Adobe
ADBE
|
+$13.3M |
| 3 |
Oracle
ORCL
|
+$11.8M |
| 4 |
Electronic Arts
EA
|
+$11.6M |
| 5 |
NXP Semiconductors
NXPI
|
+$11.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$13.8M |
| 2 |
IBM
IBM
|
+$11.3M |
| 3 |
Verizon
VZ
|
+$10.8M |
| 4 |
Morgan Stanley
MS
|
+$9.99M |
| 5 |
Qualcomm
QCOM
|
+$9.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.47% |
| 2 | Financials | 15.32% |
| 3 | Healthcare | 13.31% |
| 4 | Industrials | 11.81% |
| 5 | Consumer Discretionary | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Aptiv
APTV
$12B
| $209K | 0.01% |
2,347
-302
| -11% | -$30.8K |
|
1202
Halliburton
HAL
$26.9B
| $209K | 0.01% |
+6,658
| New | +$248K |
|
1203
Charles River Laboratories
CRL
$11.2B
| $208K | 0.01% |
972
-1,642
| -63% | -$401K |
|
1204
Hubbell
HUBB
$25B
| $208K | 0.01% |
1,166
-763
| -40% | -$144K |
|
1205
Brink's
BCO
$4.88B
| $206K | 0.01% |
3,387
-34,674
| -91% | -$2.09M |
|
1206
WSFS Financial
WSFS
$4.12B
| $203K | 0.01% |
5,057
-12,069
| -70% | -$497K |
|
1207
Essential Utilities
WTRG
$11.3B
| $201K | 0.01% |
4,375
-2,266
| -34% | -$105K |
|
1208
Watsco Inc
WSO
$12.7B
| $200K | 0.01% |
839
+164
| +24% | +$43.2K |
|
1209
Enovix
ENVX
$892M
| $194K | 0.01% |
+24,889
| New | +$234K |
|
1210
Urban Edge Properties
UE
$2.86B
| $184K | 0.01% |
+12,083
| New | +$216K |
|
|
NSTG
1211
DELISTED
NanoString Technologies, Inc.
NSTG
| $184K | 0.01% |
14,460
+6,786
| +88% | +$126K |
|
|
CDMO
1212
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $183K | 0.01% |
+11,997
| New | +$177K |
|
|
HA
1213
DELISTED
Hawaiian Holdings, Inc.
HA
| $183K | 0.01% |
+12,763
| New | +$213K |
|
1214
BioCryst Pharmaceuticals
BCRX
$2.28B
| $176K | 0.01% |
+16,621
| New | +$171K |
|
1215
Diamondrock Hospitality Co
DRH
$2.71B
| $175K | 0.01% |
21,367
-43,966
| -67% | -$429K |
|
1216
Editas Medicine
EDIT
$396M
| $167K | 0.01% |
14,101
-11,052
| -44% | -$148K |
|
|
HAPN
1217
Happen Inc
HAPN
$2.21B
| $164K | 0.01% |
14,051
-16,551
| -54% | -$233K |
|
1218
Fulton Financial
FULT
$4.66B
| $163K | 0.01% |
11,302
-16,803
| -60% | -$260K |
|
1219
Goodyear
GT
$2B
| $154K | 0.01% |
14,416
-6,745
| -32% | -$84.5K |
|
1220
Acadia Pharmaceuticals
ACAD
$4.43B
| $152K | 0.01% |
10,786
-40,760
| -79% | -$761K |
|
|
FLG
1221
Flagstar Bank National Association
FLG
$5.93B
| $152K | 0.01% |
5,543
-6,660
| -55% | -$191K |
|
|
LGF.B
1222
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $147K | 0.01% |
16,599
+5,199
| +46% | +$59.2K |
|
1223
Oceaneering
OII
$4.86B
| $142K | 0.01% |
13,277
-31,203
| -70% | -$384K |
|
1224
Iovance Biotherapeutics
IOVA
$1.82B
| $140K | 0.01% |
12,685
-4,853
| -28% | -$63.6K |
|
|
TUP
1225
DELISTED
Tupperware Brands Corporation
TUP
| $133K | 0.01% |
+20,915
| New | +$233K |
|
Similar funds
RHBC
BDF
SCA
IC
WFA
CA
RIG
CCP
AlphaCrest Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AlphaCrest Capital Management held 1,421 positions worth $2.07B, up 16% from $1.79B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
AlphaCrest Capital Management deployed $660M of net new capital in Q2 2022, opening 201 new positions and adding to 658 existing holdings. Its largest new stake was UBS Group: 397,371 shares worth $6.45M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Lowe's Companies, an estimated $13.8M trimmed.
- AlphaCrest Capital Management's largest Q2 2022 buy was UBS Group: 397,371 shares worth $6.45M.
- AlphaCrest Capital Management added most to Target in Q2 2022, an estimated $18.6M increase.
- AlphaCrest Capital Management's biggest Q2 2022 reduction was Lowe's Companies, cutting an estimated $13.8M.
- AlphaCrest Capital Management fully exited PNC Financial Services in Q2 2022, selling an estimated $4.05M.
- AlphaCrest Capital Management's ten largest holdings make up 6.3% of its $2.07B portfolio in Q2 2022.
- AlphaCrest Capital Management opened 201 new positions and closed 185 in Q2 2022.
- AlphaCrest Capital Management's portfolio value rose 16% quarter-over-quarter to $2.07B.
Based on AlphaCrest Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.